在拉丁美洲建立儿科血液学/瘤学劳动力能力
Daniel C Moreira1, Federico Antillón-Klussmann2,3, Roy Rosado2
1St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatric blood & cancer
|October 23, 2025
概括
五个拉丁美洲的儿科血液学/瘤学项目成功培养了专家. 毕业生很好地融入劳动力,为区域儿科癌症护理和领导角色做出贡献.
科学领域:
- 医学教育 医学教育
- 儿科瘤学 儿科瘤学
- 全球卫生工作人员发展
背景情况:
- 评估拉丁美洲五个儿科血液学/瘤学奖学金计划的影响.
- 分析实习生和毕业生个人资料以及他们的劳动力融合.
研究的目的:
- 评估圣朱德全球学院在拉丁美洲的合作奖学金计划的有效性.
- 了解受过培训的儿科血液学家/瘤学家的职业发展轨迹和贡献.
主要方法:
- 与拉丁美洲五个主要机构 (危地马拉,墨西哥,乌拉圭,巴西) 合作.
- 收集关于实习生来源,完成率和毕业生就业情况的数据.
- 调查毕业生关于当前的角色,责任和时间分配.
主要成果:
- 来自14个国家的110名医生接受了培训,61.8%完成了课程.
- 79.7%的受访者在儿科癌症病房工作,其中62.7%的人在培训后立即开始工作.
- 毕业生将大量时间用于儿科瘤学 (52.0%),许多人担任领导职位 (44%).
结论:
- 这些奖学金计划有效地培养了拉丁美洲儿童癌症护理专家.
- 毕业生表现出高水平的劳动力整合和区域贡献.
- 为了制定一个全面的区域劳动力战略,还需要进一步的研究.
相关概念视频
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
International Nursing Organizations II
1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


